The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.25
Bid: 6.00
Ask: 6.50
Change: 0.00 (0.00%)
Spread: 0.50 (8.333%)
Open: 6.25
High: 6.25
Low: 6.25
Prev. Close: 6.25
KMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Sir Peter Williams CBE as Chairman

28 Sep 2015 07:00

RNS Number : 2971A
Kromek Group PLC
28 September 2015
 

28 September 2015

Kromek Group plc

("Kromek" or the "Company")

 

Directorate Change

Appointment of Sir Peter Williams CBE as Chairman

 

Kromek, a radiation detection technology company focusing on the medical, security and nuclear markets, announces that Sir Peter Williams CBE has been appointed as a Non-Executive Director of the Company with immediate effect and as the Chairman of the Board of Directors with effect from the conclusion of the Company's Annual General Meeting ("AGM") to be held in October 2015. Mr Lawrence Kinet, who has held the position of Interim Chairman since 17 April 2015, will resume his role as Non-Executive Director of the Company.

 

Sir Peter Williams, aged 70, has extensive experience in science and engineering in both commercial and academic environments. He is currently Chairman of the Daiwa Anglo Japanese Foundation, a UK-based charity to support closer links between Britain and Japan, and performs advisory roles with technology companies such as Plessey Semiconductors Ltd. During his corporate career, he has held positions such as Chairman and Chief Executive of Oxford Instruments plc, senior independent non-executive director of GKN plc, non-executive director of W.S. Atkins plc and Deputy Chief Executive of VG Instruments Ltd. Other roles have included Chairman of the National Physical Laboratory, Honorary Treasurer and Vice President of the Royal Society and Chairman of the Engineering & Technology Board.

 

He has advised the UK Government on issues of science and education, including conducting the 'Williams Review' of primary mathematics in 2008 and in 2010, and was a member of the international review of the Intergovernmental Panel on Climate Change (IPCC) for the UN Secretary General. Sir Peter Williams was also a member of the science advisory board for the Prime Minister of Malaysia. He was knighted in 1998 and is a Fellow of the Royal Society and of the Royal Academy of Engineering.

 

Lawrence Kinet, Non-Executive Interim Chairman, said: "I am honoured to welcome Sir Peter Williams to the Board of Kromek. Over the last six months, we have appointed a new broker, achieved progress in our new commercial markets and completed a successful fundraising, which is supported by our revolving credit facility with HSBC. As a result, the Company is now in a stronger financial position, and we look forward to leveraging Sir Peter Williams' tremendous expertise and experience as we advance to the next stage of our development."

 

Sir Peter Williams, Non-Executive Director and Chairman Designate, added: "I am pleased to be joining Kromek at this exciting juncture. I feel I can contribute a great deal based on my significant sector experience and, in particular, my time at Oxford Instruments. I am impressed by the management team and the scale of the Company's operations. Kromek is at the leading-edge in developing radiation detection solutions at a price point that is commercially viable - which has hitherto been a challenge with uptake of CZT-based sensors. I look forward to working with the management team and my fellow members of the Board to deliver further progress and shareholder value."

 

The Company will issue a notice of AGM in due course. In accordance with Kromek's articles of association, Sir Peter Williams will be offered for re-election at the AGM: subject to the approval of the resolution, he will assume the role of Chairman from the conclusion of the meeting.

 

Other than that set out below, there are no other matters that are required to be disclosed under Schedule 2 paragraph (g) of the AIM Rules in relation to the appointment of Sir Peter Williams.

 

Regulatory disclosures:

 

Current directorships

Directorships within the last five years

London Institute for Mathematical Sciences

GKN plc

W.S. Atkins plc

NPL Management Limited

Marie Curie

Royal Society Enterprise Fund Limited

Royal Society Trading Limited

 

Enquiries:

 

Kromek Group plc

01740 626 060

Arnab Basu, CEO

Derek Bulmer, CFO

 

 

 

Cenkos Securities plc

0207 397 8900

Bobbie Hilliam (NOMAD)

Julian Morse (Sales)

 

 

 

Luther Pendragon Ltd

0207 618 9100

Harry Chathli, Claire Norbury, Alexis Gore

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAQELFLEKFFBBE
Date   Source Headline
25th Apr 20247:00 amRNSKromek receives new Nuclear Security contract
3rd Apr 20243:13 pmRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSKromek receives $2.1m security screening order
6th Mar 20243:21 pmRNSHolding(s) in Company
4th Mar 202412:16 pmRNSHolding(s) in Company
4th Mar 202411:51 amRNSResult of General Meeting
5th Feb 202410:17 amRNSConversion of £1.5m of Convertible Loan Notes
5th Feb 20247:00 amRNSKromek granted £1.3m under Horizon Europe scheme
30th Jan 20247:00 amRNSInterim Results
25th Jan 20247:00 amRNSKromek receives £1.4m CBRN order for EU stockpile
23rd Jan 20247:00 amRNSNotice of Results
18th Jan 20247:00 amRNSKromek receives $1.6m in advanced imaging orders
7th Nov 20237:00 amRNSCollaboration agreement with new CT partner
31st Oct 20237:00 amRNSKromek receives additional $1m in CBRN orders
26th Oct 20237:00 amRNSFirst US DHS Contract for Biosecurity for $5.9m
9th Oct 20234:59 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSHolding(s) in Company
28th Sep 202311:25 amRNSResult of AGM
28th Sep 20237:00 amRNSFinancing Update
14th Sep 20237:00 amRNSPartial Conversion of Convertible Loan Notes
12th Sep 20237:00 amRNSKromek detectors in new Spectrum Dynamics scanner
1st Sep 20235:00 pmRNSNotice of AGM and Publication of Annual Report
24th Jul 20237:01 amRNSFinal Results
24th Jul 20237:00 amRNSAppointment of Joint Broker
5th Jun 20237:00 amRNSNew $1.5m CBRN contract in Asia
31st May 20239:05 amRNSHolding(s) in Company
25th May 20232:48 pmRNSResult of Open Offer, General Meeting and TVR
10th May 20231:39 pmRNSNotice of Investor Webinar
5th May 20233:46 pmRNSPlacing, Subscription, Open Offer and Notice of GM
2nd May 20237:00 amRNSKromek receives medical imaging order of c.$1.4m
19th Apr 20237:00 amRNSKromek and Analogic Collaboration Agreement
18th Apr 20237:01 amRNSTrading Update
18th Apr 20237:00 amRNSSeven-Year Agreement with Tier 1 OEM
29th Mar 20237:00 amRNSKromek secures orders totalling over $1m
22nd Mar 20232:51 pmRNSHolding(s) in Company
31st Jan 20237:00 amRNSInterim Results
31st Jan 20237:00 amRNSKromek awarded c. £2.5m by Innovate UK
9th Jan 20237:00 amRNSKromek Secures $0.8m Order for D3S ID
19th Dec 20227:00 amRNSFurther agreement with Smiths Detection
15th Dec 20229:32 amEQSKromek Group 'delighted' with new contracts
12th Dec 20227:00 amRNSKromek wins £1.5m in nuclear security contracts
16th Nov 20227:00 amRNSAward of £5m bio-threat contract by UK Government
10th Nov 20227:00 amRNSKromek awarded US nuclear security contract
17th Oct 202211:42 amRNSKromek detectors used in digital SPECT/CT scanner
28th Sep 202212:27 pmRNSResult of AGM
2nd Sep 20225:26 pmRNSNotice of AGM and Publication of Annual Report
23rd Aug 202211:10 amRNSFundraising of £1.14 million
5th Aug 20227:00 amRNSFundraising of £1.7m
3rd Aug 20222:05 pmRNSSecond Price Monitoring Extn
3rd Aug 20222:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.